National and Kapodistrian University of Athens
Χαρακτηρισμός μεσεγχυματικών κυττάρων προερχόμενων από επαγόμενα βλαστοκύτταρα για τη μοντελοποίηση της εκφυλιστικής αρθρίτιδας
Abstract
dc:descriptionOsteoarthritis (OA) is the most prevalent degenerative joint disorder and a leading cause of pain and disability worldwide. It is no longer considered as a passive consequence of mechanical wear but as a dynamic, inflammatory, and multifactorial disease driven by the interplay of genetic, biomechanical, metabolic, and environmental factors. At the molecular level, OA is characterized by complex regulatory processes: alterations in the nuclear transcriptome disrupt pathways essential for cellular homeostasis, while dysregulation of non-coding RNAs (ncRNAs) perturbs the mRNA-ncRNA regulatory network, shifting the balance from anabolic toward catabolic and inflammatory processes. In parallel, increasing evidence highlights the role for the mitochondrial genome (mtDNA) in OA pathogenesis, as mtDNA variants and mitochondrial dysfunction are linked to accelerated cellular aging and loss of tissue integrity. Despite extensive research, there are no disease-modifying drugs and current clinical interventions are restricted to symptom management or surgical approaches in advanced disease stages. Mesenchymal stem cell (MSC)-based therapies are promising due to their regenerative and immunomodulatory capacity; however, their efficacy is influenced by the tissue of origin and the age/pathological condition of the donor, factors that limit their therapeutic potential. The reprogramming of induced pluripotent stem cells (iPSCs) and their differentiation into induced MSCs (iMSCs) offers a potential solution, enabling the generation of homogeneous cell populations with superior regenerative potential and suitability for disease modeling. The present PhD thesis employed a multi-omics approach, including mRNA transcriptomics, miRNA/lncRNA profiling and mtDNA variant analysis, to investigate the molecular changes occurring during the reprogramming of MSCs from OA patients into iPSCs and their subsequent differentiation into iMSCs. The objectives were to (i) elucidate the regulatory mechanisms underlying the restored biological functionality of iMSCs compared to primary MSCs, and (ii) assess whether iMSCs can serve both as an OA disease model and a candidate cell source for future regenerative applications. The experimental workflow comprised: (a) reprogramming patient-derived MSCs into iPSCs and generation of iMSCs via embryoid body (EB) formation, (b) comparative transcriptomic and ncRNA expression analyses across MSCs, iPSCs, and iMSCs, and (c) characterization of mtDNA heteroplasmy and variant burden across the same populations. Phenotypic and functional characterization confirmed successful induction of pluripotency and subsequent differentiation into iMSCs, which exhibited a mesenchymal profile (CD73⁺/CD90⁺/CD105⁺) and preserved trilineage differentiation capacity (adipogenic, chondrogenic, osteogenic). Transcriptomic analysis revealed 209 differentially expressed genes (DEGs) between iMSCs and OA-derived MSCs. One hundred and nineteen (119) out of the 209 DEGs shared common expression patterns with iPSCs, indicating that iMSCs acquired transcriptional features of pluripotency and entered a “rejuvenated” state. SFRP1/2, HMGA2, and FLT1 were among genes that were associated with increased proliferative potential, while genes including SEMA3 and TNFRSF21 were linked to MSC migration and differentiation. Integrated mRNA-miRNA profiling identified 43 DEGs regulated by 15 inversely expressed miRNAs, as hsa-let-7b/i, hsa-miR-195-5p, and hsa-miR-16-5p. Subsequent mRNA-miRNA-lncRNA network analysis uncovered a distinct competing endogenous RNA regulatory network (ceRNA) emerging during reprogramming. Central regulatory nodes included ADAMTS5, MAP3K9, HMGA2, and COL12A1, whereas lncRNAs, as MEG3, SNHG14, MIR100HG, NR2F2-AS1 and miRNAs, as hsa-miR-145, and hsa-miR-195 acted as key upstream regulators. The above findings demonstrate that reprogramming reshapes the ncRNA-mRNA regulatory landscape, reversing OA pathological molecular signatures. Mitochondrial genome analysis revealed that OA-derived MSCs exhibited high burden of heteroplasmic mtDNA variants, predominantly in OXPHOS coding regions as MT-ND1–ND4, MT-ATP8, MT-CO1 and ribosomal RNA genes, as MT-RNR1, and MT-RNR2, including variants with high pathogenicity scores. Following reprogramming and differentiation into iMSCs, the mtDNA variant load decreased, with several variants being nearly eliminated, indicating a mechanism of mitochondrial genome purification. Integration with transcriptomic data revealed five mitochondria-associated genes, COX7A1, GPAT2, MAOB, SERAC1, ECHDC2 with reduced expression in iMSCs, consistent with metabolic remodeling and restoration of mitochondrial homeostasis. In conclusion, this thesis demonstrates that reprogramming of MSCs from OA patients into iPSCs and their subsequent differentiation into iMSCs leads to profound transcriptional and mitochondrial rejuvenation, mediated through both reconfiguration of the ceRNA regulatory network and reduction of pathogenic mtDNA variants. Collectively, these findings establish iMSCs as a functionally restored cell population with enhanced biological properties and elevated therapeutic potential, supporting their use as a powerful platform for osteoarthritis modeling and possible future OA regenerative stem cell therapies.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Konteles, Vasileios
- Κοντελές, Βασίλειος
Subjects
dc:subject × 16- Οστεοαρθρίτιδα
- Επαγόμενα Βλαστοκύτταρα
- Μεταγραφωματική
- Μη-κωδικά μόρια RNA
- Μιτοχονδριακό DNA
- Osteoarthritis
- Induced Stem Cells
- Transcriptomics
- Non-coding RNAs (ncRNAs)
- Mitochondrial genome
- Άλλες Ιατρικές Επιστήμες
- Ιατρική και Επιστήμες Υγείας
- Ιατρική, άλλοι τομείς
- Other Medical Sciences
- Medical and Health Sciences
- Medicine, miscellaneous
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61182